Marshall Wace LLP Takes $416,000 Position in Molina Healthcare, Inc. (NYSE:MOH)

Marshall Wace LLP bought a new position in Molina Healthcare, Inc. (NYSE:MOH) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 1,400 shares of the company’s stock, valued at approximately $416,000.

A number of other institutional investors have also added to or reduced their stakes in the company. Innealta Capital LLC purchased a new stake in Molina Healthcare in the second quarter worth approximately $36,000. Ashton Thomas Private Wealth LLC bought a new position in shares of Molina Healthcare during the 2nd quarter valued at $40,000. AM Squared Ltd purchased a new position in Molina Healthcare in the 2nd quarter worth $59,000. Mather Group LLC. bought a new stake in Molina Healthcare in the first quarter worth $123,000. Finally, GAMMA Investing LLC boosted its position in Molina Healthcare by 11.5% during the first quarter. GAMMA Investing LLC now owns 330 shares of the company’s stock valued at $136,000 after buying an additional 34 shares during the period. Institutional investors own 98.50% of the company’s stock.

Analysts Set New Price Targets

MOH has been the subject of several recent research reports. Stephens reiterated an “equal weight” rating and issued a $320.00 price objective on shares of Molina Healthcare in a research report on Thursday, July 25th. JPMorgan Chase & Co. cut their price target on shares of Molina Healthcare from $420.00 to $395.00 and set an “overweight” rating on the stock in a report on Wednesday, July 10th. Jefferies Financial Group lowered their price objective on shares of Molina Healthcare from $354.00 to $297.00 and set a “hold” rating for the company in a research note on Wednesday, July 24th. Wells Fargo & Company raised their target price on Molina Healthcare from $315.00 to $360.00 and gave the stock an “equal weight” rating in a research note on Monday, August 5th. Finally, Deutsche Bank Aktiengesellschaft lowered their price target on Molina Healthcare from $354.00 to $353.00 and set a “hold” rating for the company in a research report on Monday, July 29th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $378.00.

Molina Healthcare Stock Down 1.5 %

Shares of NYSE MOH opened at $325.51 on Friday. Molina Healthcare, Inc. has a 12-month low of $282.96 and a 12-month high of $423.92. The stock’s fifty day simple moving average is $342.46 and its two-hundred day simple moving average is $336.82. The stock has a market capitalization of $19.07 billion, a PE ratio of 17.66, a price-to-earnings-growth ratio of 1.21 and a beta of 0.58. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.49.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings data on Wednesday, July 24th. The company reported $5.86 EPS for the quarter, topping the consensus estimate of $5.73 by $0.13. The firm had revenue of $9.88 billion during the quarter, compared to analyst estimates of $9.75 billion. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. Molina Healthcare’s revenue was up 18.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $5.65 EPS. As a group, analysts expect that Molina Healthcare, Inc. will post 23.5 EPS for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In other news, Director Steven J. Orlando sold 1,000 shares of the company’s stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total transaction of $339,210.00. Following the transaction, the director now owns 18,025 shares in the company, valued at $6,114,260.25. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the completion of the transaction, the director now owns 18,025 shares in the company, valued at $6,114,260.25. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CAO Maurice Hebert sold 393 shares of the business’s stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $346.52, for a total value of $136,182.36. Following the sale, the chief accounting officer now owns 9,473 shares in the company, valued at approximately $3,282,583.96. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by company insiders.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.